Influence of female and male sex steroids on body composition in the rabbit model

References

• Riggs BL, Khosla S, Melton U. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res 1998;13: 763–73
   Google Scholar
• Kanis JA. Estrogens, the menopause, and osteo-porosis. Bone 1996;19 (Suppl 5):185S–90S
   Google Scholar
• Roshan S, Nader S, Orlander P. Review: ageing and hormones. Eur J Clin Invest 1999;29:210–13
   PubMed Web of Science ®Google Scholar
• Bush TL. The epidemiology of cardiovascular disease in postmenopausal women. Ann NY Acad Sci 1990;592:263–71
   PubMed Web of Science ®Google Scholar
• Christiansen C. Osteoporosis: diagnosis and management today and tomorrow. Bone 1995; 17 (Suppl 5):513S–16S
   Google Scholar
• Tenover JL. Male hormone replacement therapy including `andropause'. Endocrinol Metab Gun North Am 1998;27:969–87
   PubMed Web of Science ®Google Scholar
• O'Sullivan AJ, Crampton u, Freund J, Ho KK. The route of estrogen replacement therapy confers divergent effects on substrate oxidation and body composition in postmenopausal women. J Clin Invest 1998;102:1035–40
   Google Scholar
• Kohrt WM, Landt M, Birge SJ Jr. Serum leptin levels are reduced in response to exercise training, but not hormone replacement therapy, in older women. J Gun Endocrinol Metab 1996;81: 3980–5
   Google Scholar
• Haarbo J, Marslew U, Gotfredsen A, Christiansen C. Postmenopausal hormone replacement therapy prevents central distribution of body fat after menopause. Metabolism 1991; 40:1323–6
   PubMed Web of Science ®Google Scholar
• Katznelson L, Finkelstein JS, Schoenfeld DA, Rosenthal DI, Anderson EJ, Klibanski A. Increase in bone density and lean body mass during testosterone administration in men with acquiredhypogonadism. J Clin Endocrinol Metab 1996; 81:4358–65
   PubMed Web of Science ®Google Scholar
• Young NR, Baker HW, Liu G, Seeman E. Body composition and muscle strength in healthy men receiving testosterone enanthate for contracep-tion. J Clin Endocrinol Metab 1993;77:1028–32
   PubMed Web of Science ®Google Scholar
• Mann P, Holmang S, Jonsson L, et al. The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obesity Relat Metab Disord 1992;16:991–7
   PubMed Web of Science ®Google Scholar
• Haarbo J, Gotfredsen A, Hassager C, Christiansen C. Validation of body composition by dual energy X-ray absorptiometry (DEXA). Clin Physiol 1991;11:331–41
   PubMedGoogle Scholar
• Alexandersen P, Haarbo J, Breinholt V, Christiansen C. Dietary phytoestrogens and estrogen inhibit experimental atherosclerosis. Climacteric 2001;4:151–9
   PubMedGoogle Scholar
• Alexandersen P, Haarbo J, Byrjalsen I, Lawaetz H, Christiansen C. Natural androgens in-hibit male atherosclerosis: a study in castrated, cholesterol-fed rabbits. Circ Res 1999;84: 813–19
   Google Scholar
• Haarbo J, Leth-Espensen P, Stender S, Christiansen C. Estrogen monotherapy and com-bined estrogen—progestogen replacement therapy attenuate aortic accumulation of cholesterol in ovariectomized cholesterol-fed rabbits. J Clin Invest 1991;87:1274–9
   PubMed Web of Science ®Google Scholar
• Svendsen OL, Haarbo J, Hassager C, Christiansen C. Accuracy of measurements of body composition by dual-energy X-ray absorp-tiometry in vivo. Am J Clin Nutr 1993;57:605–8
   PubMed Web of Science ®Google Scholar
• Hansen B, Sorensen NK. Internal report. Research Center Foulum, Denmark, 1996;76:81
   Google Scholar
• SAS Institute Inc. SAS/STAT guide for personal computers, version 6. Cary, NC: SAS Institute Inco, 1987
   Google Scholar
• Mitchell AD, Scholz AM, Pursel VG, Evock-Clover CM. Composition analysis of pork car-casses by dual-energy X-ray absorptiometry. J Anim Sci 1998;76:2104–14
   Google Scholar
• Hassager C, Christiansen C. Estrogen/gestagen therapy changes soft tissue body composition in postmenopausal women. Metabolism 1989;38: 662–5
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Ciaponi M, Cappagli B, et al. Body weight, body fat distribution, and hor-monal replacement therapy in early postmeno-pausal women. J Clin Endocrinol Metab 1997; 82:414–17.
   PubMed Web of Science ®Google Scholar
• Aloia JF, Vaswani A, Russo L, Sheehan M, Flaster E. The influence of menopause and hor-monal replacement therapy on body cell mass and body fat mass. Am J Obstet Gynecol 1995;172:896–900
   Google Scholar
• Hanggi W, Lippuner K, Jaeger P, Birkhauser MH, Horber FF. Differential impact of conven-tional oral or transdermal hormone replacement therapy or tibolone on body composition in post-menopausal women. Clin Endocrinol (Oxf) 1998;48:691–9
   Google Scholar
• Stachenfeld NS, DiPietro L, Palter SF, Nadler ER. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women. Am J Physiol 1998;27:R187–95
   Google Scholar
• Gambacciani M, Ciaponi M, Cappagli B, BenussiC, De Simone L, Genazzani AR. Climacteric modifications in body weight and fat tissue distri-bution Climacteric 1999;2:37–44
   Google Scholar
• Martini G, Valenti R, Giovani S, Nuti R. Age-related changes in body composition of healthy and osteoporotic women. Maturitas 1997;27: 25–33
   PubMed Web of Science ®Google Scholar
• Crandall DL, Buster DE, Novak TJ, Weber RV, Kral JG. Identification of estrogen receptor [3 RNA in human breast and abdominal sub-cutaneous adipose tissue. Biochem Biophys Res Commun 1998;248: 523–6
   Google Scholar
• Kahlert S, Grohe C, Karas RH, Lobbert K, Neyses L, Vetter H. Effects of estrogen on skeletal myoblast growth. Bioch em B iop hys Res Commun 1997;232:373–8
   PubMed Web of Science ®Google Scholar
• Welle S, Jozefowicz R, Forbes G, Griggs RC. Effect of testosterone on metabolic rate and body composition in normal men and men with muscu-lar dystrophy. J Clin Endocrinol Metab 1992;74: 332–5
   PubMed Web of Science ®Google Scholar
• Wang C, Eyre DR, Clark R, et al. Sublingual testosterone replacement improves muscle mass and strength, decreases bone resorption, and increases bone formation markers in hypo-gonadal men — a clinical research center study. J Clin Endocrinol Metab 1996;81:3654–62
   PubMed Web of Science ®Google Scholar
• Brodsky IG, Balagopal P, Nair KS. Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men — a clinical research center study. J Clin Endocrinol Metab 1996;81:3469–75
   Google Scholar
• Vogiatzi MG, Boeck MA, Vlachopapadopoulou E, el-Rashid R, New MI. Dehydroepiandro-sterone in morbidly obese adolescents: effects on weight, body composition, lipids, and insulin resistance. Metabolism 1996;45:1011–15
   Google Scholar
• Flynn MA, Weaver-Osterholtz D, Sharpe-Timms KL, Allen S, Krause G. Dehydroepiandrosterone replacement in aging humans. J Clin Endocrinol Metab 1999;84:1527–33
   PubMed Web of Science ®Google Scholar
• Hyyppa S, Karvonen U, Rasanen LA, Persson SG, Poso AR. Androgen receptors and skeletal muscle composition in trotters treated with nandrolone laureate. Zentralbl Veterinarmed A 1997;44: 481–91
   Google Scholar
• Bricout VA, Serrurier BD, Bigard AX, Guezennec CY. Effects of hindlimb suspension and androgen treatment on testosterone receptors in rat skeletal muscles. Eur J Appl Physiol 1999;79:443–8
   Web of Science ®Google Scholar